newsfilter
← Latest News
GlobeNewswire·

LumiraDx Submits First 510(k) Application to the FDA for COVID Ultra Test

LONDON, June 30, 2023 (GLOBE NEWSWIRE) -- LumiraDx Limited (NASDAQ:LMDX), a leading innovator in diagnostic technologies, today announced the submission of its first 510(k) application to the U.S. Food and Drug